z-logo
open-access-imgOpen Access
Intestinal Epithelial Restitution After TcdB Challenge and Recovery From Clostridium difficile Infection in Mice With Alanyl-Glutamine Treatment
Author(s) -
Raphael Silva Rodrigues,
Renato A. C. Oliveira,
Yuesheng Li,
Snjezana ZajaMilatovic,
Lourrany Borges Costa,
Manuel B. Braga Neto,
Glynis L. Kolling,
Aldo Â. M. Lima,
Richard L. Guerrant,
Cirle A. Warren
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit041
Subject(s) - clostridium difficile , microbiology and biotechnology , glutamine , restitution , clostridium difficile toxin a , c difficile , virology , biology , clostridium , immunology , medicine , antibiotics , bacteria , amino acid , biochemistry , genetics , political science , law
Clostridium difficile is an anaerobic bacterium that causes antibiotic-associated diarrhea. It produces toxin A and toxin B (TcdB), which cause injury to the gut epithelium. Glutamine is a fundamental fuel for enterocytes, maintaining intestinal mucosal health. Alanyl-glutamine (AQ) is a highly soluble dipeptide derivative of glutamine. We studied whether administration of AQ ameliorates the effects of TcdB in the intestinal cells and improves the outcome of C. difficile infection in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom